NME23 program

Nanomed Europe 23 is an in-person conference including keynotes, plenary sessions about academic research in Nanomedicine, translation towards the clinic & trends in disruptive medical technologies. Social events will give you lots of opportunities for networking & will help initiate new collaborations.

Have a look below at the tentative program we’ve prepared for you!

ETPN2002 Program overview

Please find below the detailed program of Nanomed Europe 23!

Day 0 – Monday, June 19, 2023

}

08:30am – 9:15am

HUB502 LT1

Registration (for ETPN members only)

}

09:15am – 12:00pm

Hub502 LT1

ETPN Association, General Assembly (part 1)

By the ETPN Bureau & Secretariat

FOR ETPN MEMBERS ONLY

}

12:00Pm – 2:00pm

HUB502

Lunch

}

2:00PM – 4:30PM

HUB502 LT1

ETPN Association, General Assembly (part 2)

By the ETPN Bureau & Secretariat

FOR ETPN MEMBERS ONLY

}

FROM 6PM

Museum of Liverpool - Atrium

NME23 Welcome cocktail!

Open to all NME23 attendees!

Day 1 – Tuesday, June 20, 2023 

}

08:00am – 08:50am

HUB502 LT1

Registration

}

08:50AM - 09:00 AM

HUB502 LT1

NME23 Opening ceremony

Welcoming words from the NME23 Organization Commitee.

}

09:00AM - 10:00 AM

HUB502 LT1

Keynote#1 

Prof. Molly Stevens

“Designing nanomaterials for therapeutics and ultrasensitive biosensing.”

Professor of Biomedical Materials and Regenerative Medicine at Imperial College London.

}

10:00AM - 10:30 AM

Courtyard

Poster exhibition

}

10:30AM - 11:00 AM

Courtyard

Coffee break

}

11:00AM - 12:30PM

HUB502 LT1 & LT2

BIOLOGICAL barriers to overcome to address unmet clinical needs

Chair: Prof. Steven Conlan, chair of the British Society for nanomedicine.

CLICK FOR INFO & SPEAKERS

INVITED SPEAKER:

  • Prof. Maria J Alonso (University of Santiago de Compostela -USC)

SELECTED SPEAKERS:

  • Prof. Paolo Decuzzi (Italian Institute of Technology) A conformable microMESH for brain tumor chemo-immunotherapy
  • Dr. Lucía Martín-Banderas (Universidad de Sevilla) Cannabinoid-loaded PLGA Active nanoparticles for atherosclerosis treatment
  • Dr. Aadarash Zia (Medicines Discovery Catapult) – NUVEC® Silica Nanoparticles as Efficient Non-Viral Intracellular Delivery System for Nucleic acids
  • Dr. Giuseppe Mantovani (School of Pharmacy, University of Nottingham) – Sweet routes to immunomodulation

TRANSLATIONAL barriers to overcome to address unmet clinical needs

Chair: Dr. Alexandre Ceccaldi, General Secretary of the ETPN

CLICK FOR INFO & SPEAKERS

INVITED SPEAKERS

  • Dr. Angel del Pozo (Biokeralty Research Institute) – “Open Innovation Test Beds as translation boosters: a real-world case in nano-enabled cancer therapy.”
  • Dr. Julianna Haggerty (CPI – Centre of Excellence – LNP and IntraCellular Drug Delivery) – “Building an advanced UK capability in delivery of nucleic acid therapies – joining the dots to support the Nanomed ecosystem.”
  • Dr. Lorna FitzPatrick (Medicines Discovery Catapult) – “MDC supporting industry to progress the development of new nanomedicines.”
}

12:30PM - 2:00 PM

Courtyard

Lunch

}

2:00PM - 2:15pm

HUB502

Sponsor talk

Dr. Stéphane MalzanBusiness Development Director (EMEA)

“Nanoparticles: Automating your Research for Isolation and Accurate Single Particle Characterisation”

}

2:15pm - 4:00pm

HUB502 LT1

Plenary session – ELRIG UK special event

“Complex Medicines: The next generation of therapeutics”

Chairs: Sarah Brockbank, Medicines Discovery Catapult Jarrod Walsh, AstraZeneca

CLICK FOR INFO & SPEAKERS
  • Sarah Brockbank (Medicines Discovery Catapult)  Jarrod Walsh (AstraZeneca)  – Session introduction
  • Marianne Ashford (AstraZeneca) – “Design & Development of Nanomedicines to Improve Therapeutic Index”
  • Arpan Desai, (Nanovation Therapeutics) – “Lipid Nanoparticles for enabling genomic medicines”
  • Sally Price (Evox Therapeutics ) – “Exosomes for targeted delivery of therapeutics.”
  • Joint Discussion & Q&A Session
}

4:00PM - 4:30PM

Courtyard

Coffee break

}

4:30PM - 6:00PM

HUB502 LT1 & LT2

Nano-enabled MEDICAL DEVICES & IVD

Chair: Prof. Maya Thanou – King’s College London

CLICK FOR INFO & SPEAKERS

INVITED SPEAKER:

  • Dr. Lorena Dieguez (International Iberian Nanotechnology Laboratory)

SELECTED SPEAKERS:

  • Gil Gonçalves (University of Aveiro/TEMA) – “Carbon nanocapsules for lithium neutron capture therapy (LiNCT)”
  • Francisco Rodríguez-Gómez (Pompeu Fabra University / Asphalion S.L.) – “Classification System for Nanotechnology-enabled Health Products with both Scientific and Regulatory Application”
  • Javier Bonet (University of Zaragoza) – “Labile copper imaging as a tool to study cancer cell response towards therapeutic nanoparticles.”
  • Carlos Rodriguez-Nogales (Université de Genève) – “Spray-dried chitosan microspheres for the intra-articular delivery of disease-modifying osteoarthritis kartogenin nanocrystals.”

 

The “Next Big Thing” in Nanomedicine

Chair: Prof. Ray Schiffelers, chairman of the ETPN

CLICK FOR INFO & SPEAKERS

INVITED SPEAKERS

  • Dr. Laurent Lévy (Nanobiotix) – Title TBC soon
  • Dr. Camille de Villiers (SPARTA Biodiscovery Ltd – Imperial College London) – SPARTA®, Enabling nanoformulations for next-generation therapeutics
  • Dr. Susanna Piluso (SentryX) – “Clinical stage hydrogel platform for localized sustained release of small molecules.”
}

6:00PM - 6:15PM

HUB502 LT1

HIGHLIGHTS of DAY 1!

}

From 7:00PM

Titanic Rum Warehouse

NME23 Gala dinner

No particluar dress code i.e. formal/black tie is set, we’re going for smart to smart-casual attire. Come as you are!

Day 2 – Wednesday, June 21, 2023

}

8:00am - 09:00AM

HUB502

Registration

}

09:00AM - 10:00AM

HUB502 LT1

Keynote#2  Prof. Yvonne Perrie, 

“Enhancing the delivery of next generation RNA therapies through formulation design.”

Head of Institute, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde.

}

10:00 - 10:30AM

Courtyard

Poster exhibition

}

10:30AM - 11:00AM

Courtyard

Coffee break

}

11:00AM - 12:30AM

HUB502 LT1 & LT2

BIOSAFETY & nanotoxicology

Chair: Dr. Neill Liptrott (University of Liverpool)

CLICK FOR INFO & SPEAKERS

INVITED SPEAKER:

  • Prof. Shareen Doak (Swansea University)

SELECTED SPEAKERS:

  • Miss Cintia Baptista Marques (University of Geneva) – “Influence of nanoparticle charge on interaction with key proteins from protein corona – an in vitro-in vivo correlation study
  • Dr. Paul Cressey (Apeikon Therapeutics & King’s College London) – “Development and safety studies for a FUS triggered carboplatin and SN-38 loaded thermosensitive liposomes for triple negative breast cancer treatment.”
  • Ms. Mariona Estape Senti (UMC Utrecht)  – “Anti-peg antibodies compromise the integrity of pegylated lipid-based nanoparticles via complement”
  • Dr. Padmaja Nampi (University of Leeds) – “Upconversion nanoparticles for biosensing and bioimaging applications.”

BROKERAGE event: 

Upcoming funding opportunities for Nanomedicine in Europe.

CLICK FOR INFO & SPEAKERS

To be confirmed soon. Stay tuned!

}

12:30PM - 2:00PM

Courtyard

Lunch

}

2:00PM - 2:15pm

HUB502 LT1

Sponsor talk


Dr.Cameron Burns, Application Scientist

Nano-flow cytometry as a tool to determine LNP quality & encapsulation efficiency.

}

2:15pm - 4:00pm

HUB502

Plenary session

“Regulatory issues in Nanomedicine”

Chair: Prof. Scott McNeill, University of Basel
Moderator: Alexandre Ceccaldi

CLICK FOR INFO & SPEAKERS

INVITED SPEAKERS

  • Prof. Scott McNeill, Professor at the University of Basel (25 min presentation + Q&A)
  • Dr. Ka-Wai Wan, Senior Pharmaceutical Assessor at MHRA (15 min presentation + Q&A)

PANELISTS

  • Dr. Sally Price  Senior Director – Translational Medicine of Evox Therapeutics
  • Dr. Laurent Lévy, CEO and founder of Nanobiotix (remotely)
  • Dr. Arpan Desai Managing Director of Nanovation Therapeutics
  • Dr. Ka-Wai Wan
  • Prof. Scott McNeill
}

4:00PM - 4:30PM

Courtyard

Coffee break

}

4:30PM - 6:00PM

HUB502 LT1 & LT2

GENE THERAPY & Nucleic acids delivery

Chair: Prof. Lewis Francis – Swansea University

CLICK FOR INFO & SPEAKERS

INVITED SPEAKER:

  • Prof. Alvaro Somoza Calatrava (IMDEA Nanociencia)

SELECTED SPEAKERS:

  • Dr Flávia Sousa (Adolphe Merkle Institute – University of Fribourg) – “Intratumoral IL-12 delivery through immunostimulatory nanoparticles empowers glioblastoma immunotherapy.”
  • Miss Ying Sun (Queen’s University Belfast) – “Delivery of nucleic acid cargo by 3D printed PCL-PEG-Chitosan patches for wound healing.”
  • Dr Giampaolo Zuccheri (Alma Mater Studiorum Università di Bologna) – “The activation of microglia in neuroinflammation and its mitigation by functional self-assembled DNA nanostructures.”
  • Miss Sofia Miron Barroso (Imperial College London) -“Methacrylate-based star co-polymer for delivery of anti-miRNA100 and 125b for pancreatic cancer treatment.”

EUROPEAN PROJECTS in Nanomedicine

Chair: Lorena Dieguez, Leader of the WG on Medical devices at the ETPN.

CLICK FOR INFO & SPEAKERS
  • PHOENIX –  Dr. Dr. Tommaso Serchi (LIST)Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical innovative products.”
  • NANOCARB – Marco Monopoli (Royal College of Surgeons in Ireland (RCSI)) – “Glyco-Nanoparticles for Applications in Advanced Nanomedicine.”
  • EXPERT – Prof. Raymond Schiffelers  (UMC Utrecht) – “Off-the-Shelf mRNA Nanomedicines.”
  • NANOSPRESSO NL – Prof. Raymond Schiffelers  (UMC Utrecht) – “Local preparation of high-quality, personalised nucleic acid nanomedicines.”
  • LEAD-TO-TREAT – Dr. Andreas Aslund (SINTEF) – “Developing a platform for future treatment of multi-resistant microbial infections.”
  • MetrINo – Dr. Fanny Caputo (LNE) – “Metrology for Innovative NanoTherapeutics.”
}

6:00PM - 6:15PM

HUB502 LT1

HIGHLIGHTS of DAY 2!

}

FROM 7PM

The Hope and Anchor

Biotech & Beers social event

Biotech & Beers returns to Liverpool, at The Hope and Anchor, after the 3rd day of the NanoMed Europe 2023 Conference!

Join Bionow and Marks & Clerk for an agenda-free networking evening which provides opportunities for key people from companies working in or with the life sciences sector to network and socialise with their peers in an informal setting over a drink or two, it’s a chance to network with others you havent had the chance to chat to at the conference.

Day 3 – Thursday, June 22, 2023

}

8:00AM - 09:00AM

HUB502

Registration

}

09:00AM - 10:30AM

HUB502 LT1 & LT2

Cell Engineering & REGENERATIVE medicine

Chair: Prof. Maya Thanou – King’s College London

CLICK FOR INFO & SPEAKERS

INVITED SPEAKER:

  • Dr. Sabine van Rijt (MERLN Institute for Technology-Inspired Regenerative Medicine)

SELECTED SPEAKERS:

  • Mrs. Andrea Haiek (Fundación CIDETEC) – “A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis.”
  • Dr. Eleonora Bianchi (University of Pavia)  – “Thermoplastic polyurethane-based scaffolds enriched with chondroitin sulphate and cerium oxide for the treatment of tendon injuries“.
  • Dr. Ahmed Elkashif (Queen’s University Belfast) – “Delivery of microRNA 26a via a Peptide-Based Nanoparticle for Healing of Large Bone Defects.”
  • Dr Sibel Cetinel (Sabanci University) – “Nano-Approaches in Ocular Neovascularization Treatment.”

DISRUPTIVE MEDICINE: HealthTech in action!

Chair: Kathleen Spring, vice-chairperson of the ETPN

CLICK FOR INFO & SPEAKERS
  • Dr. Eamonn Hawe (Tyndall National Institute) – “Digital Healthtech underpinned by key enabling technologies.”
  • Prof. Françoise Siepel (DIH-HERO, University of Twente)  – “How robotics can make a change in the healthcare sector.”
  • More info to be announced, please stay tuned!
}

10:30AM - 11:00AM

Courtyard

Coffee break

}

11:00AM - 12:30PM

HUB502 LT1 & LT2

PERSONALIZED medicine & rare diseases

Chair: Prof. Christine Dufès – University of Strathclyde

CLICK FOR INFO & SPEAKERS

INVITED SPEAKER:

  • Dr. Alejandro J Paredes -Queen’s University Belfast

SELECTED SPEAKERS:

  • Dr. Ioanna Mela (University of Cambridge Royal Society University) – “DNA nanostructures for targeted antimicrobial delivery”
  • Ms. Mareike Werle (Queen Mary University London) – “Polymer nanoparticles as a targeted drug delivery system for the diagnosis and treatment of rheumatoid arthritis.”
  • Dr. Manuel Bañobre-López (International Iberian Nanotechnology Laboratory) –“Targetless solid tumor targeting through smart magnetic nanocomposites.”
  • Prof. Lewis Francis (Swansea University)  – “Pharmacogenomic platforms for drug re-purposing and future Nanomedicines.”

“PITCH me up!” Nanomedicine innovation in translation to the clinic

Chair: Alexandre Ceccaldi, General Secretary of the ETPN

CLICK FOR INFO & SPEAKERS
  • Audrey Nsamela (Inside Tx) – “Liposomes manufacturing with GENISIS: an innovative Microfluidic Nanoparticle Synthesis platform.”
  • Marco Monopoli (Royal College of Surgeons in Ireland (RCSI)) – “Use of nanoparticles as a prefractionation tool for a glycan base early warning diagnostics.”
  • Dr Cian McCrudden (Queen’s University Belfast) – “Beyond the LNP: Peptide delivery of a therapeutic mRNA vaccine for HPV16-driven malignancies”
  • Inge Nelissen (VITO nv) – “Novel fluorescence centrifugation-based technology for multi-parameter (nano)particle analysis in complex samples.”
  • Wafa Al-Jamal (Queen’s University Belfast) – “Liposome- Indocyanine Green J- Aggregates as Biodegradable and Highly Stable Photothermal Agents For Cancer Therapy.”
  • Aikaterini Lalatsa (University of Strathclyde Reader) – “G-FiberS; Peptide Nanofibers for Targeting Glioblastoma Multiforme.”
}

12:30PM - 1:30PM

COURTYARD

Light lunch

}

1:30PM - 2PM

HUB502 LT1 & LT2

ANTIMICROBIAL nanomaterials

Chair: Thomas McDonald (University of Manchester)

CLICK FOR INFO & SPEAKERS

SELECTED SPEAKERS:

    • Dr. Jenny Aveyard (University of Liverpool)  – “Loaded Gelatin Nanoparticles as Antimicrobial Therapeutics for the Treatment of Respiratory Infections.”
    • Miss Ana González-Paredes (Instituto de Química Médica-Consejo Superior de Investigaciones Científicas) – “Lipid nanoparticles as a strategy against bacterial biofilm-associated infections.”

    CHARACTERIZATION of nanomedicines

    Chair: Prof. Lewis Francis – Swansea University

    CLICK FOR INFO & SPEAKERS
    • SELECTED SPEAKERS:

      • Dr Florian Meier (Postnova Analytics GmbH) – “Multi-detector Field-Flow Fractionation for the assessment of Critical Quality Attributes of nano-sized drug delivery systems.”
      • Dr Elizabeth Legge (National Physical Laboratory NPL) -“Quantitative chemical measurements of liposome formulations using Raman spectroscopy”
    }

    2:00pm - 2:15pm

    HUB502

    NME23 closing:
    Prize giving ceremony for the Best Talk & Best Poster awards.

    Kindly sponsored by: 

    }

    2:30PM - 4:30PM

    HUB502 (room to be announced on spot)

    NME23 Satellite event MetrINo workshop: 

    Advancing on characterisation and standardisation methods: the regulatory needs and the industrial perspective”

    INFO & REGISTRATION

    FREE but MANDATORY REGISTRATION by CLICKING HERE.

    We are delighted to invite you to an exclusive free-of-charge workshop on “Advancing on characterisation and standardisation methods in Nanomedicine: The regulatory needs and the industrial perspective” organized by the new MetrINo project in Liverpool on June 22, 2023 by the afternoon (hybrid event), as part of the broader scientific conference Nanomed Europe 2023. This conference is the most important event this year in Europe focusing on the medical applications of nanotechnology.

    Why should you participate in this workshop?

    Our workshop, organized within the framework of the new EURAMET project MetrINo will specifically address the regulatory challenges of nanomedicine, providing a unique opportunity to share your expectations, discuss the critical issues facing our sector and the priorities for advancing standardisation actions and development of reference materials that are fit for purpose for medicinal products and medical devices containing nanomaterials on the market or on trials (your developed products). With a highly interactive format, your expertise and opinions will directly contribute to the prioritization of future actions of the European metrology community, and more broadly for prioritising new developments of reference materials and standard test methods internationally.

    Your experience and expertise of your company in the field would bring a lot to the discussion. We will focus the agenda on very concrete initiatives that the MetrINo project will develop in the 3 coming years to address the immediate metrological needs expressed by industry, regulatory agencies and policymakers to develop and validate traceable measurement methods and reference materials (RMs) for the assessment of the critical quality attributes (CQAs) of nanotherapeutics.

    More globally, we strongly encourage you to participate in the NME23 3-day conference, notably in the plenary session on the “Regulatory challenges of nanomedicine”. Don’t miss this chance to collaborate with other leaders in the field, influence regulatory development, and shape the future of nanomedicine in Europe. Join us for this must-attend event and together, let’s overcome challenges and build a prosperous future for our industry.

    In addition to the informative and interactive workshop, we are pleased to offer a variety of networking opportunities and social events throughout Nanomed Europe 2023. By attending, you will have the chance to connect with key decision-makers, researchers, and industry experts from across Europe, fostering valuable partnerships and collaborations. Register now to secure your place and take advantage of early-bird discounts.

    Furthermore, participants of the MetrIno workshop will receive exclusive access to post-event resources, including workshop presentations and a summary report detailing the outcomes and recommendations. Don’t miss this unique opportunity to gain insights into the latest nanomedicine advancements, and contribute to shaping the regulatory landscape of our industry.

     
    About MetrINo:

    MetrINo-Metrology for Nanotherapeutics, starting the 1st June 2023 , is the first European collaborative project financed by the EURAMET (European Associations of National Metrology Institutes) to respond to immediate metrological needs in the field of nanomedicine expressed in the last 5 years by industry, regulatory agencies and policymakers. It aims to develop and validate traceable measurement methods and reference materials for the quality assessment of innovative nanotherapeutics, and for their detections in cells and tissues, that are fit for purpose for the formulations in the clinics. The main focus is on synthetic lipid-based, e.g., liposomes and LNPs-RNA, and metal oxide nanoparticles. The highly multidisciplinary consortium coordinated by the French Metrology Institute (LNE), and composed by 9 metrology institutes, the ETPN association, 2SME, 1 pharmaceutical industry, 1 hospital and 6 academic partners, aims at making Europe a leading player in the field of metrology applied to nanomedicine, and to support the industrial stakeholders internationally in the implementation of EMA, medical device regulation (MDR) and FDA directives by contributing to the development of suitable reference materials and consensus standards.

    Register Now!

    Ready to join us in Liverpool for Nanomed Europe 23? The registration process only takes a few minutes!

    Contact Us

    6 + 2 =